Questo è quello che abbiamo trovato per te
Research has tied obstructive sleep apnea to an increased risk of cardiovascular disease and death. So far, though, the mechanism underlying the association has been unclear.
Esperimento alla Cleveland Clinic, allevia preoccupazioni
Autore/Fonte: Journal of Clinical Oncology
Autore/Fonte: NICE
Autore/Fonte: Danilo Mourglia, Saul Fina, Federico Gennaro, Simonetta Miozzo
Gli operatori: “Reazione sorprendente” con la bambola iconica
Gli operatori: “Reazione sorprendente” con la bambola iconica
Studio, 5 minuti in più scoprono pazienti a rischio effetti collaterali
Stroke, Ahead of Print. BACKGROUND:The aim of this study was to characterize change in sleep-disordered breathing severity in the year following stroke, overall, and by ethnicity, within the population-based Brain Attack Surveillance in Corpus Christi Project.METHODS:First-ever ischemic strokes (n=414) were ascertained by active and passive surveillance and validated by stroke-trained physicians. Patients with stroke were invited to participate in portable sleep apnea testing (ApneaLink Plus) at baseline and 3, 6, and 12 months poststroke. Sleep-disordered breathing severity was assessed by the respiratory event index (apneas and hypopneas/hour of recording). The component obstructive apnea index and central apnea index were also assessed. Time and ethnicity effects on outcomes, as well as ethnic differences in time effects, were analyzed using generalized estimating equations with multivariable adjustment for confounding factors.RESULTS:Mean age (n=414) was 63.9 years (SD=10.9); 68.4% were Mexican American. Baseline mean respiratory event index, obstructive apnea index, and central apnea index were 21.3 (SD=16.6), 8.6 (SD=11.5), and 1.5 (SD=3.2), respectively. There was no time effect on respiratory event index (P=0.35) but obstructive apnea index increased over time (P
Stroke, Ahead of Print.
La probabilità sale con gli anni di uso, studio
La probabilità sale con gli anni di uso, studio
Una procedura al cervello per curare una malattia ultra rara
A base di acido bempedoico, alternativa alle statine
Studio della Fondazione Italiana Linfomi guidato dal Cro Aviano
Studio della Fondazione Italiana Linfomi guidato dal Cro Aviano
